Cytokines and growth factors regulate growth, differentiation, and activation across lymphocytes, mast cells, endothelial cells, and beyond. This section covers interleukins, interferons, chemokines, the TNF superfamily, colony-stimulating factors, and growth factor families such as TGF-β, VEGF, EGF, and FGF—supporting immunology, cell biology, and drug discovery.
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
| Catalog # | Product / Synonym | Species | Expression | Protein structure |
|---|---|---|---|---|
| NECTIN4-HB002 | Human | Human; HEK293; Recombinant Biotinylated Human Nectin-4 Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Gly32-Val351 (UniProt accession: Q96NY8-1). | Nectin-4AviHis N-terminusC-terminus AA segmentGly32-Val351 | |
| NECTIN2-CP001 | Cynomolgus | Cynomolgus; HEK293; Recombinant Cynomolgus Nectin-2/CD112 Protein is expressed in HEK293 cells with a His tag at the C-terminus. It contains amino acid residues Gln32-Gly360 (UniProt accession: A0A2K5U084). | Nectin-2/CD112His N-terminusC-terminus AA segmentGln32-Gly360 | |
| MSLN-HP002 | Human | Human; HEK293; Recombinant FITC-Labeled Human MSLN/Mesothelin Protein is expressed in HEK293 cells with an hFc (IgG1) tag at the C-terminus. It contains amino acid residues Glu296-Gly580 (UniProt accession: Q13421-2). | FITC-Labeled Human MSLN/MesothelinFc N-terminusC-terminus AA segmentGlu296-Gly580 | |
| MAGEA4-HB004 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and KVLEHVVRV peptide | HLA-A*02:01&B2M&MAGE-A4 (KVLEHVVRV) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| LMP2-HP003 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and CLGGLLTMV peptide | HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| LMP2-HB002 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and CLGGLLTMV peptide | HLA-A*02:01&B2M&LMP2 (CLGGLLTMV) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| LILRB4-MB001 | Mouse | Mouse; HEK293; Recombinant Biotinylated Mouse LILRB4/CD85k/ILT3 Protein (Primary Amine Labeling) is expressed in HEK293 cells with a His tag at the C-terminus. It contains amino acid residues Gly24-Lys238 (UniProt accession: Q64281-1). | LILRB4/CD85k/ILT3His N-terminusC-terminus AA segmentGly24-Lys238 | |
| LILRB4-HB004 | Human | Human; HEK293; Recombinant Biotinylated Human LILRB4/CD85k/ILT3 Domain 1+hinge Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Gln22-Lys123 (UniProt accession: Q8NHJ6-1). | LILRB4/CD85k/ILT3 Domain 1+hingeAviHis N-terminusC-terminus AA segmentGln22-Lys123 | |
| LILRB4-HB002 | Human | Human; HEK293; Recombinant Biotinylated Human LILRB4/CD85k/ILT3 Domain 1 Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Gln22-Thr118 (UniProt accession: Q8NHJ6-1). | LILRB4/CD85k/ILT3 Domain 1AviHis N-terminusC-terminus AA segmentGln22-Thr118 | |
| LILRB4-CP001 | Cynomolgus | Cynomolgus; HEK293; Recombinant Cynomolgus LILRB4/CD85k/ILT3 Protein Protein is expressed in HEK293 cells with a His tag at the C-terminus. It contains amino acid residues Gln22-Glu259 (accession: XP_015297198.1). | LILRB4/CD85k/ILT3His N-terminusC-terminus AA segmentGln22-Glu259 | |
| LILRB1-HB002 | Human | Human; HEK293; Recombinant Biotinylated Human LILRB1/CD85j/ILT2 Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Gly24-His458 (UniProt accession: Q8NHL6-1). | LILRB1/CD85j/ILT2AviHis N-terminusC-terminus AA segmentGly24-His458 | |
| KRASG12V-HP011 | Human | Human; HEK293; Gly25-Thr305(HLA-A*03:01), Ile21-Met119(B2M) and VVGAVGVGK peptide | PE-Labeled Human HLA-A*03:01&B2M&KRAS G12V (VVGAVGVGK) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12V-HP008 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGAVGVGK peptide | HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12V-HB006 | Human | Human; E. coli; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGAVGVGK peptide | HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12S-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGASGVGK peptide | HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12D-HB003 | Human | Human; E. coli; Gly25-Thr305(HLA-A*11:01), Ile21-Met119 (B2M) and VVVGADGVGK peptide | HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HPV16E7-HP003 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and YMLDLQPET peptide | HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HLAA0201-HP014 | Human | Human; E. coli; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and FLLPTGAEA peptide | APC-Labeled Human HLA-A*02:01&B2M&CG1 (FLLPTGAEA) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HLAA0201-HP010 | Human | Human; E. coli; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and TLIRWAILEA peptide | HLA-A*02:01&B2M&Foxp3 (TLIRWAILEA) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HLAA0201-HB003 | Human | Human; E. coli; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and AAPGAPAAV peptide | HLA-A*02:01&B2M&ARF (AAPGAPAAV) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 |
